Related Experiment Videos
Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
J Siderov1, P Prasad, R De Boer
1Pharmacy Department, Austin & Repatriation Medical Centre, Studley Road, Heidelberg, Australia. jim.siderov@armc.org.au
British Journal of Cancer
|February 22, 2002
Abstract:
Etoposide is commonly used in a variety of malignancies. A well known but rare toxicity are hypersensitivity reactions, usually manifested by chest discomfort, dyspnoea, bronchospasm and hypotension. We report the details of a patient who developed hypersensitivity reactions to intravenous etoposide, but subsequently tolerated the administration of intravenous etoposide phosphate with no sequelae.